PPB - Services

Complaints, Feedback and Enquiry

๐๐๐ ๐€๐๐ฏ๐š๐ง๐œ๐ž๐ฌ ๐“๐จ๐ฐ๐š๐ซ๐๐ฌ ๐ˆ๐Œ๐ƒ๐‘๐… ๐Œ๐ž๐ฆ๐›๐ž๐ซ๐ฌ๐ก๐ข๐ฉ: ๐’๐ญ๐ซ๐ž๐ง๐ ๐ญ๐ก๐ž๐ง๐ข๐ง๐  ๐†๐ฅ๐จ๐›๐š๐ฅ ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐’๐ญ๐š๐ง๐๐š๐ซ๐๐ฌ – 14th March 2024

Washington DC – On March 14th, 2024, PPB took a significant step towards global collaboration and regulatory excellence. Under the leadership of CEO, Dr. F.M. Siyoi, the team convened in Washington DC to submit an application to join the International Medical Device Regulators Forum (IMDRF) as an affiliate member. During the Management Committee Closed Session, Dr. Kariuki Gachoki, Head of HPTs at PPB, presented the application, reaffirming PPB’s commitment to enhancing regulatory standards and fostering global cooperation in the medical device field.

Becoming an affiliate member of IMDRF will open doors to invaluable opportunities for learning and collaboration with regulatory authorities worldwide. IMDRF includes regulatory bodies from Australia, Brazil, Canada, China, the European Union, Japan, Singapore, South Korea, the United Kingdom, and the United States.

Author

Public Relations

Leave a comment

Your email address will not be published. Required fields are marked *